Chris Lomma

510 total citations
8 papers, 336 citations indexed

About

Chris Lomma is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chris Lomma has authored 8 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Cancer Research and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chris Lomma's work include Pancreatic and Hepatic Oncology Research (2 papers), Breast Cancer Treatment Studies (2 papers) and Cancer Genomics and Diagnostics (2 papers). Chris Lomma is often cited by papers focused on Pancreatic and Hepatic Oncology Research (2 papers), Breast Cancer Treatment Studies (2 papers) and Cancer Genomics and Diagnostics (2 papers). Chris Lomma collaborates with scholars based in Australia, United States and New Zealand. Chris Lomma's co-authors include Michael Millward, Elin S. Gray, Mel Ziman, Tarek Meniawy, Muhammad A. Khattak, James Freeman, Kelvin Shenq Woei Siew, Anna Reid, Johnny Lo and Adam Cooper and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Oncotarget.

In The Last Decade

Chris Lomma

6 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chris Lomma Australia	4	215	207	146	91	45	8	336
Joanna Kapeleris Australia	8	186 0.9×	251 1.2×	74 0.5×	117 1.3×	29 0.6×	14	340
Sebastián A. García Germany	8	155 0.7×	231 1.1×	101 0.7×	53 0.6×	60 1.3×	11	346
Cenzhu Wang China	7	146 0.7×	153 0.7×	183 1.3×	56 0.6×	57 1.3×	14	310
Saskia Hussung Switzerland	9	186 0.9×	188 0.9×	112 0.8×	71 0.8×	15 0.3×	19	279
Elisabeth Breit Germany	7	174 0.8×	210 1.0×	86 0.6×	64 0.7×	12 0.3×	8	315
Shouman Wang China	12	111 0.5×	159 0.8×	154 1.1×	49 0.5×	48 1.1×	29	342
Ellen Honisch Germany	8	296 1.4×	198 1.0×	263 1.8×	43 0.5×	14 0.3×	13	420
Masaki Murase Japan	6	89 0.4×	232 1.1×	170 1.2×	68 0.7×	93 2.1×	8	341
Caroline Hego France	7	178 0.8×	156 0.8×	131 0.9×	77 0.8×	112 2.5×	8	394
Zhuang Tong China	5	83 0.4×	151 0.7×	100 0.7×	66 0.7×	96 2.1×	5	272

Countries citing papers authored by Chris Lomma

Since Specialization

Citations

This map shows the geographic impact of Chris Lomma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Lomma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Lomma more than expected).

Fields of papers citing papers by Chris Lomma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Lomma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Lomma. The network helps show where Chris Lomma may publish in the future.

Co-authorship network of co-authors of Chris Lomma

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Lomma. A scholar is included among the top collaborators of Chris Lomma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Lomma. Chris Lomma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Dean, Andrew, Katrin Marie Sjoquist, Val Gebski, et al.. (2025). AGITG ASCEND: Randomised, double-blind phase II study of certepetide or placebo added to gemcitabine plus nab-paclitaxel in patients with untreated metastatic pancreatic ductal adenocarcinoma: Initial results.. Journal of Clinical Oncology. 43(4_suppl). 728–728.

2.

Lee, Woo Jin, Il Hwan Kim, Chris Lomma, et al.. (2024). 324P Effect of NALIRIFOX in Asian patients (pts) with treatment-naive metastatic pancreatic adenocarcinoma (mPAC): Results from the NAPOLI 3 trial. Annals of Oncology. 35. S136–S137. 1 indexed citations

3.

Lomma, Chris, HuiJun Chih, & Arlene Chan. (2023). Adjuvant Dose Dense Chemotherapy in Patients With Obesity: Short-Term Toxicities and Breast Cancer Outcome. Clinical Breast Cancer. 23(5). 491–499.

4.

Acheampong, Emmanuel, Michael Morici, Aaron B. Beasley, et al.. (2022). Evaluation of PD-L1 expression on circulating tumour cells in small-cell lung cancer. Translational Lung Cancer Research. 11(3). 440–451. 18 indexed citations

5.

Lomma, Chris, et al.. (2020). Male Breast Cancer in Australia. Asia-Pacific Journal of Clinical Oncology. 17(2). e57–e62. 7 indexed citations

6.

Lomma, Chris & David Ransom. (2018). Chemotherapy dosing and toxicity in a patient with muscular dystrophy. Cancer Reports. 1(2). e1106–e1106. 3 indexed citations

7.

Freeman, James, Chris Lomma, Markus H. Frank, et al.. (2017). Isolation and detection of circulating tumour cells from metastatic melanoma patients using a slanted spiral microfluidic device. Oncotarget. 8(40). 67355–67368. 47 indexed citations

8.

Gray, Elin S., Helen Rizos, Anna Reid, et al.. (2015). Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma. Oncotarget. 6(39). 42008–42018. 260 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact